PSC

Patient Square Capital Portfolio holdings

AUM $374M
1-Year Est. Return 90.79%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+90.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$374M
AUM Growth
+$96.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
27
New
Increased
Reduced
Closed

Top Buys

1
+$12.9M
2
+$10.2M
3
+$4.94M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$4.92M
5
QURE icon
uniQure
QURE
+$4.38M

Top Sells

1
+$14.1M
2
+$9.96M
3
+$6.54M
4
SRRK icon
Scholar Rock
SRRK
+$5.45M
5
EYPT icon
EyePoint Inc
EYPT
+$4.86M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$15.1B
$189M 50.51%
12,480,000
INSM icon
2
Insmed
INSM
$33.1B
$47M 12.57%
326,400
-32,400
EYPT icon
3
EyePoint Inc
EYPT
$1.13B
$14.4M 3.85%
1,011,839
-340,998
ABVX
4
Abivax
ABVX
$8.73B
$12.9M 3.45%
+151,833
CDTX
5
DELISTED
Cidara Therapeutics
CDTX
$11.6M 3.1%
121,000
+106,000
ARGX icon
6
argenx
ARGX
$52.1B
$11.4M 3.06%
15,500
-13,500
LQDA icon
7
Liquidia Corp
LQDA
$3.69B
$9.1M 2.43%
400,000
-620,000
PHVS icon
8
Pharvaris
PHVS
$1.74B
$8.62M 2.31%
345,381
+101,098
OCUL icon
9
Ocular Therapeutix
OCUL
$1.93B
$8.36M 2.24%
715,000
-102,699
MIRM icon
10
Mirum Pharmaceuticals
MIRM
$6.13B
$7.64M 2.04%
104,262
-9,200
AGIO icon
11
Agios Pharmaceuticals
AGIO
$1.59B
$5.37M 1.44%
133,827
-5,905
KYMR icon
12
Kymera Therapeutics
KYMR
$5.78B
$5.24M 1.4%
92,592
-47,408
ELVN icon
13
Enliven Therapeutics
ELVN
$1.57B
$5.13M 1.37%
250,838
+5,000
CELC icon
14
Celcuity
CELC
$5.04B
$4.94M 1.32%
+100,000
DNTH icon
15
Dianthus Therapeutics
DNTH
$2.27B
$4.92M 1.32%
+125,000
IRON icon
16
Disc Medicine
IRON
$2.94B
$4.89M 1.31%
74,000
QURE icon
17
uniQure
QURE
$1.39B
$4.38M 1.17%
+75,000
AMLX icon
18
Amylyx Pharmaceuticals
AMLX
$1.55B
$4.3M 1.15%
+316,312
NRIX icon
19
Nurix Therapeutics
NRIX
$1.68B
$4.04M 1.08%
437,237
+24,941
ALLO icon
20
Allogene Therapeutics
ALLO
$409M
$3.7M 0.99%
2,981,396
+346,396
ASMB icon
21
Assembly Biosciences
ASMB
$409M
$3.46M 0.93%
+135,182
AVTX icon
22
Avalo Therapeutics
AVTX
$274M
$1.27M 0.34%
+100,000
CATX icon
23
Perspective Therapeutics
CATX
$282M
$1.2M 0.32%
+349,323
GERN icon
24
Geron
GERN
$855M
$1.16M 0.31%
845,000
+129,000
SRRK icon
25
Scholar Rock
SRRK
$4.53B
– –
-154,000
1
2